Biotech news for Thursday, July 9, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
primeimages Stock futures edged up Thursday morning as markets showed resilience despite a spike in energy prices following President Donald Trump's declaration that the brief ceasefire with Iran is “over.” Here are some of Thursday's biggest stock movers: Big…
Shares of Vera Therapeutics ( VERA ) jumped on Tuesday after the U.S. Food and Drug Administration approved the company’s kidney disease therapy, atacicept, under its accelerated pathway. According to the FDA, the once-weekly injectable branded as Trutakna wil…
The European Commission has authorized a label expansion for Tepkinly, a blood cancer therapy jointly developed by AbbVie ( ABBV ) and Genmab ( GMAB ) as part of a combination regimen for patients with follicular lymphoma. Accordingly, the bispecific antibody…
Bitcoin ( BTC-USD ) price slumped in June, going as low as $58K. For the entire month, U.S. spot bitcoin ETFs recorded $4.5B in net outflows, marking their worst month since their launch in January 2024, according to SoSoValue. The June outflows
Shares of Kailera Therapeutics ( KLRA ) slipped more than 10% on Tuesday after the Waltham, Massachusetts-based biotech reported topline data from two late-stage trials conducted in China for its oral GLP-1 candidate HRS-7535 (KAI-7535). The Phase 3 HARBOR-1 t…
koto_feja/E+ via Getty Images The EU drug regulator, the European Medicines Agency, on Tuesday announced plans to accelerate the review of daraxonrasib, a highly anticipated pancreatic cancer drug from Revolution Medicines (RMED). The EMA said that its human m…